Despite the fact that this patient’s symptoms did not exactly mimic those of idiopathic PD, SCA3 or Machado-Joseph disease (MJD) was the first genetically verified SCA subtype in a patient with the levodopa-responsive Parkinson’s disease (PD) similar phenotype. Here, ATXN3 is linked to Machado-Joseph disease.